Bifidobacterium bifidum PRL2010 Modulates the Host Innate Immune Response

Applied and Environmental Microbiology

Volumn 80, Issue 2, 2014, Pages 730-740

  Turroni, Francesca ^a   Taverniti, Valentina ^b   Ruas Madiedo, Patricia ^c   Duranti, Sabrina ^d   Guglielmetti, Simone ^b   Lugli, Gabriele Andrea ^d   Gioiosa, Laura ^d   Palanza, Paola ^d   Margolles, Abelardo ^c   van Sinderen, Douwe ^a   Ventura, Marco ^c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF MILAN   (Italy)

^c DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIFIDOBACTERIUM BIFIDUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN CELL LINES; INNATE IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINAL CELLS; TRANSCRIPTION PROFILES; TRANSCRIPTOME PROFILING;

CELL CULTURE; IMMUNE SYSTEM; TRANSCRIPTION;

ENZYME ACTIVITY;

BACTERIUM; COLONIZATION; IMMUNE RESPONSE; IMMUNITY; IMMUNOASSAY;

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROBIOTIC AGENT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIFIDOBACTERIUM; CACO 2 CELL LINE; CELL LINE; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HT 29 CELL LINE; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE; METABOLISM; MICROBIOLOGY; MOUSE; PHYSIOLOGY;

ANIMALS; BIFIDOBACTERIUM; CACO-2 CELLS; CELL LINE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HT29 CELLS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-8; INTESTINES; MICE; MICE, INBRED BALB C; NF-KAPPA B; PROBIOTICS;

EID: 84892449724     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03313-13     Document Type: Article

References (76)

1. Ventura M, Canchaya C, Fitzgerald GF, Gupta RS, van Sinderen D. 2007 Genomics as a means to understand bacterial phylogeny and ecological adaptation: the case of bifidobacteria. Antonie Van Leeuwenhoek 91:351-372. http://dx.doi.org/10.1007/s10482-006-9122-6.
2. Ventura M, O'Flaherty S, Claesson MJ, Turroni F, Klaenhammer TR, van Sinderen D, O'Toole PW. 2009. Genome-scale analyses of healthpromoting bacteria: probiogenomics. Nat. Rev. Microbiol. 7:61-71. http://dx.doi.org/10.1038/nrmicro2047.
3. Foroni E, Serafini F, Amidani D, Turroni F, He F, Bottacini F, O'Connell Motherway M, Viappiani A, Zhang Z, Rivetti C, van Sinderen D, Ventura M. 2011. Genetic analysis and morphological identification of pilus-like structures in members of the genus Bifidobacterium. Microb. Cell Fact. 10(Suppl 1):S16. http://dx.doi.org/10.1186/1475-2859-10-S1-S16.
4. O'Connell Motherway M, Zomer A, Leahy SC, Reunanen J, Bottacini F, Claesson MJ, O'Brien F, Flynn K, Casey PG, Munoz JA, Kearney B, Houston AM, O'Mahony C, Higgins DG, Shanahan F, Palva A, de Vos WM, Fitzgerald GF, Ventura M, O'Toole PW, van Sinderen D. 2011. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved hostcolonization factor. Proc. Natl. Acad. Sci. U. S. A. 108:11217-11222. http://dx.doi.org/10.1073/pnas.1105380108.
5. Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, Motherway MO, Shanahan F, Nally K, Dougan G, van Sinderen D. 2012 Bifidobacterial surface-exopolysaccharide facilitates commensalhost interaction through immune modulation and pathogen protection. Proc. Natl. Acad. Sci. U. S. A. 109:2108-2113. http://dx.doi.org/10.1073/pnas.1115621109.
6. Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, Zomer A, Sanchez B, Bidossi A, Ferrarini A, Giubellini V, Delledonne M, Henrissat B, Coutinho P, Oggioni M, Fitzgerald GF, Mills D, Margolles A, Kelly D, van Sinderen D, Ventura M. 2010. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc. Natl. Acad. Sci. U. S. A. 107:19514-19519. http://dx.doi.org/10.1073/pnas.1011100107.
7. Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, Whitehead TR, Lapidus A, Rokhsar DS, Lebrilla CB, German JB, Price NP, Richardson PM, Mills DA. 2008. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. Acad. Sci. U. S. A. 105:18964-18969. http://dx.doi.org/10.1073/pnas.0809584105.
8. Weiss G, Rasmussen S, Nielsen Fink L, Jarmer H, Nohr Nielsen B, Frokiaer H. 2010. Bifidobacterium bifidum actively changes the gene expression profile induced by Lactobacillus acidophilus in murine dendritic cells. PLoS One 5:e11065. http://dx.doi.org/10.1371/journal.pone.0011065.
9. Lopez P, Gonzalez-Rodriguez I, Gueimonde M, Margolles A, Suarez A. 2011 Immune response to Bifidobacterium bifidum strains support Treg/ Th17 plasticity. PLoS One 6:e24776. http://dx.doi.org/10.1371/journal.pone.0024776.
10. Turroni F, Milani C, van Sinderen D, Ventura M. 2011. Genetic strategies for mucin metabolism in Bifidobacterium bifidum PRL2010: an example of possible human-microbe co-evolution. Gut Microbes 2:183- 189. http://dx.doi.org/10.4161/gmic.2.3.16105.
11. Turroni F, Foroni E, Montanini B, Viappiani A, Strati F, Duranti S, Ferrarini A, Delledonne M, van Sinderen D, Ventura M. 2011. Global genome transcription profiling of Bifidobacterium bifidum PRL2010 under in vitro conditions and identification of reference genes for quantitative real-time PCR. Appl. Environ. Microbiol. 77:8578-8587. http://dx.doi.org/10.1128/AEM.06352-11.
12. Turroni F, Serafini F, Foroni E, Duranti S, O'Connell Motherway M, Taverniti V, Mangifesta M, Milani C, Viappiani A, Roversi T, Sanchez B, Santoni A, Gioiosa L, Ferrarini A, Delledonne M, Margolles A, Piazza L, Palanza P, Bolchi A, Guglielmetti S, van Sinderen D, Ventura M. 2013. Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions. Proc. Natl. Acad. Sci. U. S. A. 110:11151- 11156. http://dx.doi.org/10.1073/pnas.1303897110.
13. Lopez P, Gueimonde M, Margolles A, Suarez A. 2010. Distinct Bifidobacterium strains drive different immune responses in vitro. Int. J. Food Microbiol. 138:157-165. http://dx.doi.org/10.1016/j.ijfoodmicro.2009.12.023.
14. Guglielmetti S, Tamagnini I, Mora D, Minuzzo M, Scarafoni A, Arioli S, Hellman J, Karp M, Parini C. 2008. Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl. Environ. Microbiol. 74:4695-4702. http://dx.doi.org/10.1128/AEM.00124-08.
15. Taverniti V, Stuknyte M, Minuzzo M, Arioli S, De Noni I, Scabiosi C, Cordova ZM, Junttila I, Hamalainen S, Turpeinen H, Mora D, Karp M, Pesu M, Guglielmetti S. 2013. S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity. Appl. Environ. Microbiol. 79:1221-1231. http://dx.doi.org/10.1128/AEM.03056-12.
16. Stuknyte M, De Noni I, Guglielmetti S, Minuzzo M, Mora D. 2011. Potential immunomodulatory activity of bovine casein hydrolysates produced after digestion with proteinases of lactic acid bacteria. Int. Dairy J. 21:763-769. http://dx.doi.org/10.1016/j.idairyj.2011.04.011.
17. O'Flaherty S, Klaenhammer TR. 2012. Influence of exposure time on gene expression by human intestinal epithelial cells exposed to Lactobacillus acidophilus. Appl. Environ. Microbiol. 78:5028-5032. http://dx.doi.org/10.1128/AEM.00504-12.
18. Serafini F, Turroni F, Guglielmetti S, Gioiosa L, Foroni E, Sanghez V, Bartolomucci A, Motherway MO, Palanza P, van Sinderen D, Ventura M. 2012. An efficient and reproducible method for transformation of genetically recalcitrant bifidobacteria. FEMS Microbiol. Lett. 333:146- 152. http://dx.doi.org/10.1111/j.1574-6968.2012.02605.x.
19. Sleator RD, Gahan CG, Hill C. 2001. Mutations in the listerial proB gene leading to proline overproduction: effects on salt tolerance and murine infection. Appl. Environ. Microbiol. 67:4560-4565. http://dx.doi.org/10.1128/AEM.67.10.4560-4565.2001.
20. Serafini F, Bottacini F, Viappiani A, Baruffini E, Turroni F, Foroni E, Lodi T, van Sinderen D, Ventura M. 2011. Insights into physiological and genetic mupirocin susceptibility in bifidobacteria. Appl. Environ. Microbiol. 77:3141-3146. http://dx.doi.org/10.1128/AEM.02540-10.
21. Turroni F, Foroni E, O'Connell Motherway M, Bottacini F, Giubellini V, Zomer A, Ferrarini A, Delledonne M, Zhang Z, van Sinderen D, Ventura M. 2010. Characterization of the serpin-encoding gene of Bifidobacterium breve 210B. Appl. Environ. Microbiol. 76:3206-3219. http://dx.doi.org/10.1128/AEM.02938-09.
22. Bilban M, Buehler LK, Head S, Desoye G, Quaranta V. 2002. Defining signal thresholds in DNA microarrays: exemplary application for invasive cancer. BMC Genomics 3:19. http://dx.doi.org/10.1186/1471-2164-3-19.
23. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193. http://dx.doi.org/10.1093/bioinformatics/19.2.185.
24. Flores M, Hsiao TH, Chiu YC, Chuang EY, Huang Y, Chen Y. 2013. Gene regulation, modulation, and their applications in gene expression data analysis. Adv. Bioinformatics 2013:360678. http://dx.doi.org/10.1155/2013/360678.23573084.
25. Engle MJ, Goetz GS, Alpers DH. 1998. Caco-2 cells express a combination of colonocyte and enterocyte phenotypes. J. Cell. Physiol. 174:362-369. http://dx.doi.org/10.1002/(SICI)1097-4652(199803)174:3362::AID-JCP103.0.CO;2-B.
26. Pozo-Rubio T, Mujico JR, Marcos A, Puertollano E, Nadal I, Sanz Y, Nova E. 2011. Immunostimulatory effect of faecal Bifidobacterium species of breast-fed and formula-fed infants in a peripheral blood mononuclear cell/Caco-2 co-culture system. Br. J. Nutr. 106:1216-1223. http://dx.doi.org/10.1017/S0007114511001656.
27. Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Stuknyte M, Karp M, Mora D. 2010. Oral bacteria as potential probiotics for the pharyngeal mucosa. Appl. Environ. Microbiol. 76:3948-3958. http://dx.doi.org/10.1128/AEM.00109-10.
28. Wang Z, Wang J, Cheng Y, Liu X, Huang Y. 2011. Secreted factors from Bifidobacterium animalis subsp. lactis inhibit NF-kappaB-mediated interleukin- 8 gene expression in Caco-2 cells. Appl. Environ. Microbiol. 77: 8171-8174. http://dx.doi.org/10.1128/AEM.06145-11.
29. Lakhdari O, Tap J, Beguet-Crespel F, Le Roux K, de Wouters T, Cultrone A, Nepelska M, Lefevre F, Dore J, Blottiere HM. 2011. Identification of NF-kappaB modulation capabilities within human intestinal commensal bacteria. J. Biomed. Biotechnol. 2011:282356. http://dx.doi.org/10.1155/2011/282356.21765633.
30. Greene JD, Klaenhammer TR. 1994. Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl. Environ. Microbiol. 60:4487-4494.
31. Buck BL, Altermann E, Svingerud T, Klaenhammer TR. 2005. Functional analysis of putative adhesion factors in Lactobacillus acidophilus NCFM. Appl. Environ. Microbiol. 71:8344-8351. http://dx.doi.org/10.1128/AEM.71.12.8344-8351.2005.
32. Guglielmetti S, Tamagnini I, Minuzzo M, Arioli S, Parini C, Comelli E, Mora D. 2009. Study of the adhesion of Bifidobacterium bifidum MIMBb75 to human intestinal cell lines. Curr. Microbiol. 59:167-172. http://dx.doi.org/10.1007/s00284-009-9415-x.
33. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. 2004. Interleukin- 10 and related cytokines and receptors. Annu. Rev. Immunol. 22:929-979. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104622.
34. Rich BE. 2003. IL-20: a new target for the treatment of inflammatory skin disease. Expert Opin. Ther. Targets 7:165-174. http://dx.doi.org/10.1517/14728222.7.2.165.
35. Hsu YH, Li HH, Hsieh MY, Liu MF, Huang KY, Chin LS, Chen PC, Cheng HH, Chang MS. 2006. Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum. 54:2722-2733. http://dx.doi.org/10.1002/art.22039.
36. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, Artis D. 2010. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J. Exp. Med. 207:1293-1305. http://dx.doi.org/10.1084/jem.20092054.
37. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-281. http://dx.doi.org/10.1038/nm1710.
38. Munoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, Plickert R, Bereswill S, Fischer A, Dunay IR, Wolk K, Loddenkemper C, Krell HW, Libert C, Lund LR, Frey O, Holscher C, Iwakura Y, Ghilardi N, Ouyang W, Kamradt T, Sabat R, Liesenfeld O. 2009. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206:3047-3059. http://dx.doi.org/10.1084/jem.20090900.
39. Licona-Limon P, Kim LK, Palm NW, Flavell RA. 2013. TH2, allergy and group 2 innate lymphoid cells. Nat. Immunol. 14:536-542. http://dx.doi.org/10.1038/ni.2617.
40. Trepicchio WL, Ozawa M, Walters IB, Kikuchi T, Gilleaudeau P, Bliss JL, Schwertschlag U, Dorner AJ, Krueger JG. 1999. Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J. Clin. Invest. 104:1527-1537. http://dx.doi.org/10.1172/JCI6910.
41. Leng SX, Elias JA. 1997. Interleukin-11 inhibits macrophage interleukin- 12 production. J. Immunol. 159:2161-2168.
42. Opal SM, Keith JC, Palardy JE, Parejo N. 2000. Recombinant human interleukin-11 has anti-inflammatory actions yet does not exacerbate systemic Listeria infection. J. Infect. Dis. 181:754-756. http://dx.doi.org/10.1086/315247.
43. Manousou P, Kolios G, Valatas V, Drygiannakis I, Bourikas L, Pyrovolaki K, Koutroubakis I, Papadaki HA, Kouroumalis E. 2010. Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies. Clin. Exp. Immunol.162:337-347. http://dx.doi.org/10.1111/j.1365-2249.2010.04248.x.
44. Doll D, Keller L, Maak M, Boulesteix AL, Siewert JR, Holzmann B, Janssen KP. 2010. Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. Int. J. Colorectal Dis. 25:573-581. http://dx.doi.org/10.1007/s00384-010-0901-1.
45. Friederichs J, Rosenberg R, Mages J, Janssen KP, Maeckl C, Nekarda H, Holzmann B, Siewert JR. 2005. Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression. Int. J. Colorectal Dis. 20:391-402. http://dx.doi.org/10.1007/s00384-004-0722-1.
46. Lehrke M, Konrad A, Schachinger V, Tillack C, Seibold F, Stark R, Parhofer KG, Broedl UC. 2008. CXCL16 is a surrogate marker of inflammatory bowel disease. Scand. J. Gastroenterol. 43:283-288. http://dx.doi.org/10.1080/00365520701679249.
47. Messerini L, Cianchi F, Cortesini C, Comin CE. 2006. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Hum. Pathol. 37:1259-1267. http://dx.doi.org/10.1016/j.humpath.2006.04.023.
48. Mantovani A, Gray PA, Van Damme J, Sozzani S. 2000. Macrophagederived chemokine (MDC). J. Leukoc. Biol. 68:400-404.
49. Berin MC, Dwinell MB, Eckmann L, Kagnoff MF. 2001. Production of MDC/CCL22 by human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 280:G1217-G1226.
50. Sonnier DI, Bailey SR, Schuster RM, Gangidine MM, Lentsch AB, Pritts TA. 2012. Proinflammatory chemokines in the intestinal lumen contribute to intestinal dysfunction during endotoxemia. Shock 37:63-69. http://dx.doi.org/10.1097/SHK.0b013e31823cbff1.
51. Jugde F, Alizadeh M, Boissier C, Chantry D, Siproudhis L, Corbinais S, Quelvennec E, Dyard F, Campion JP, Gosselin M, Bretagne JF, Semana G, Heresbach D. 2001. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis. Eur. Cytokine Netw. 12:468-477.
52. Middel P, Raddatz D, Gunawan B, Haller F, Radzun HJ. 2006. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 55:220-227. http://dx.doi.org/10.1136/gut.2004.063008.
53. Hillinger S, Yang SC, Batra RK, Strieter RM, Weder W, Dubinett SM, Sharma S. 2006. CCL19 reduces tumour burden in a model of advanced lung cancer. Br. J. Cancer 94:1029-1034. http://dx.doi.org/10.1038/sj.bjc.6603061.
54. Hartl FU, Hayer-Hartl M. 2002. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295:1852-1858. http://dx.doi.org/10.1126/science.1068408.
55. Basu S, Srivastava PK. 2000. Heat shock proteins: the fountainhead of innate and adaptive immune responses. Cell Stress Chaperones 5:443- 451. http://dx.doi.org/10.1379/1466-1268(2000)0050443:HSPTFO 2.0.CO;2.
56. Srivastava P. 2002. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2:185-194. http://dx.doi.org/10.1038/nri749.
57. Todryk SM, Gough MJ, Pockley AG. 2003. Facets of heat shock protein 70 show immunotherapeutic potential. Immunology 110:1-9. http://dx.doi.org/10.1046/j.1365-2567.2003.01725.x.
58. Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, Gastpar R, Issels RD. 2002. Heat shock protein 70: role in antigen presentation and immune stimulation. Int. J. Hyperthermia 18:563-575. http://dx.doi.org/10.1080/02656730210166140.
59. Kregel KC. 2002. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J. Appl. Physiol. 92:2177- 2186. http://dx.doi.org/10.1152/japplphysiol.01267.2001.11960972.
60. Lecuit M, Sonnenburg JL, Cossart P, Gordon JI. 2007. Functional genomic studies of the intestinal response to a foodborne enteropathogen in a humanized gnotobiotic mouse model. J. Biol. Chem. 282:15065- 15072. http://dx.doi.org/10.1074/jbc.M610926200.
61. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:361-367. http://dx.doi.org/10.1038/86373.
62. Yu J, Ebert MP, Miehlke S, Rost H, Lendeckel U, Leodolter A, Stolte M, Bayerdorffer E, Malfertheiner P. 2000. alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relatives. Gut 46:639-644. http://dx.doi.org/10.1136/gut.46.5.639.
63. Gallo RL, Hooper LV. 2012. Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 12:503-516. http://dx.doi.org/10.1038/nri3228.
64. Lai Y, Gallo RL. 2009. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30:131-141. http://dx.doi.org/10.1016/j.it.2008.12.003.
65. Monk PN, Partridge LJ. 2012. Tetraspanins: gateways for infection. Infect. Disord. Drug Targets 12:4-17. http://dx.doi.org/10.2174/187152612798994957.
66. van Spriel AB, Figdor CG. 2010. The role of tetraspanins in the pathogenesis of infectious diseases. Microbes Infect. 12:106-112. http://dx.doi.org/10.1016/j.micinf.2009.11.001.
67. Murphy EC, Morgelin M, Cooney JC, Frick IM. 2011. Interaction of Bacteroides fragilis and Bacteroides thetaiotaomicron with the kallikreinkinin system. Microbiology 157:2094-2105. http://dx.doi.org/10.1099/mic.0.046862-0.
68. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K. 1997 Molecular cloning of a gene encoding a new type of metalloproteinase- disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J. Biol. Chem. 272:556-562. http://dx.doi.org/10.1074/jbc.272.1.556.
69. Apte SS. 2004. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: theADAMTSfamily. Int. J. Biochem. Cell Biol. 36:981-985. http://dx.doi.org/10.1016/j.biocel.2004.01.014.
70. Yoshimura T, Tomita T, Dixon MF, Axon AT, Robinson PA, Crabtree JE. 2002. ADAMs (A disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa. J. Infect. Dis. 185:332-340. http://dx.doi.org/10.1086/338191.
71. Burkholder KM, Bhunia AK. 2010. Listeria monocytogenes uses Listeria adhesion protein (LAP) to promote bacterial transepithelial translocation and induces expression of LAP receptor Hsp60. Infect. Immun. 78:5062- 5073. http://dx.doi.org/10.1128/IAI.00516-10.
72. Bevins CL, Martin-Porter E, Ganz T. 1999. Defensins and innate host defence of the gastrointestinal tract. Gut 45:911-915. http://dx.doi.org/10.1136/gut.45.6.911.
73. Hassuna N, Monk PN, Moseley GW, Partridge LJ. 2009. Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections. BioDrugs 23:341-359. http://dx.doi.org/10.2165/11315650-000000000-00000.
74. Stadnicki A. 2011. Intestinal tissue kallikrein-kinin system in inflammatory bowel disease. Inflamm. Bowel Dis. 17:645-654. http://dx.doi.org/10.1002/ibd.21337.
75. Green CD, Olson LK. 2011. Modulation of palmitate-induced endoplasmic reticulum stress and apoptosis in pancreatic beta-cells by stearoyl- CoA desaturase and Elovl6. Am. J. Physiol. Endocrinol. Metab. 300:E640- E649. http://dx.doi.org/10.1152/ajpendo.00544.2010.
76. Shimamura K, Takahashi H, Kitazawa H, Miyamoto Y, Nagumo A, Tang C, Dean D, Nagase T, Sato N, Tokita S. 2009. Identification and characterization of a selective radioligand for ELOVL6. J. Biochem. 146: 429-437. http://dx.doi.org/10.1093/jb/mvp088.